1 Min Read
Oct 20 (Reuters) - Rhythm Pharmaceuticals Inc:
* orbimed Advisors reports a 10.7 percent stake in Rhythm Pharmaceuticals Inc as of october 10 - sec filing Source text - bit.ly/2zoRqRx Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.